Torax Medical develops and markets products designed to restore human sphincter function. Our technology platform, Magnetic Sphincter Augmentation (MSA), uses attraction forces to augment weak or defective sphincter muscles to treat Gastroesophageal Reflux Disease (GERD) and Fecal Incontinence (FI).
News
April 24, 2012 - Top U.S. Medical Centers Offering New Minimally Invasive Procedure for Reflux Disease
Torax Medical today announced Keck Medical Center of USC, Mayo Clinic Florida, and UC San Diego Health System of UCSD are among the first centers offering a new procedure using the LINX® Reflux Management System, recently approved by the U.S. Food and Drug Administration (FDA).
More Press Releases
March 27, 2012 - FDA Approves LINX® System for the Treatment of Reflux Disease
Torax Medical today announced that the U.S. Food
and Drug Administration (FDA) approved the LINX® Reflux Management System for use in
patients diagnosed with Gastroesophageal Reflux Disease (GERD).
More Press Releases